Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Autolus Therapeutics PLC Sponsored ADR (AUTL) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$75.39M
Net Income	$-287.53M
Cost of Goods Sold	$96.37M
Gross Profit	$-20.98M
Operating Expenses	$345.93M
Operating Income	$-270.54M
Non-Operating Income/Expense	$-15.01M
Pre-Tax Income	$-285.56M
Normalized Pre-Tax Income	$-285.56M
Income after Taxes	$-287.53M
Income from Continuous Operations	$-287.53M
Consolidated Net Income/Loss	$-287.53M
Normalized Income after Taxes	$-287.53M
EBIT	$-270.54M
EBITDA	$-260.73M
Weighted-Average Shares Outstanding (Basic)	266.14M
Weighted-Average Shares Outstanding (Diluted)	266.14M
Earnings per Share (EPS) (Basic)	$-1.08
Earnings per Share (EPS) (Diluted)	$-1.08
Balance Sheet Financials
Current Assets	$435.92M
Property, Plant, and Equipment	$63.56M
Long-Term Assets	$153.15M
Total Assets	$589.07M
Current Liabilities	$73.44M
Long-Term Debt	--
Long-Term Liabilities	$337.50M
Total Liabilities	$410.94M
Common Equity	$178.13M
Tangible Shareholders Equity	$158.32M
Shareholders Equity	$178.13M
Common Shares Outstanding	266.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-283.57M
Cash Flow from Investing Activities	$158.46M
Cash Flow from Financial Activities	$-4.34M
Beginning Cash	$228.81M
End Cash	$105.64M
Increase/Decrease in Cash	$-123.17M
Stock-Based Compensation	$14.44M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	-27.83%
Operating Margin	-358.87%
EBIT Margin	-358.87%
EBITDA Margin	-345.85%
Pre-Tax Profit Margin	-378.78%
Profit Margin	-381.40%
Free Cash Flow	$-302.61M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	2.90
Receiveable Turnover	3.14
Days Sales in Receivables	116.32
Return on Equity	-161.42%
Return on Tangible Equity	-181.61%
Return on Assets	-48.81%
Return on Investments	-161.42%
Book Value Per Share	$0.67
Free Cash Flow per Share	$-1.14
Operating Cash Flow per Share	$-1.07

Data from Zacks Investment Research, Inc.